Tyrosine kinase inhibitor for kidney cancer
Votrient (pazopanib) is indicated for the treatment of advanced renal cell carcinoma...
MIMS
MIMS News
Cannabinoid medicine for spasticity associated with MS
The first cannabinoid licensed for use in multiple sclerosis.
Diovan for paediatric use
Diovan (valsartan) 40mg and 320mg tablets have had their licences extended to...
MHRA restricts quinine use
The MHRA has issued guidance that quinine should not be considered a...
New indication for Tyverb
Tyverb (lapatinib) has had its licence extended to include use in combination...
Deleted products 2010
The following products have been discontinued from the UK market this year....
First antibody treatment for osteoporosis
Prolia (denosumab) is indicated for the treatment of osteoporosis in postmenopausal women...
New LABA inhaler for COPD
Novartis has launched Onbrez Breezhaler (indacaterol), a dry-powder inhaler containing a novel...
Celecoxib for familial adenomatous polyposis
Onsenal is a new preparation of the COX-2 inhibitor celecoxib, indicated for...
Arzerra: new leukaemia antibody
GlaxoSmithKline has launched a new biological treatment for chronic lymphocytic leukaemia (CLL).
Somatropin NICE approval extended
Somatropin (synthetic human growth hormone) can now be prescribed on the NHS...
Pentasa Sachets licensed for paediatric use
Pentasa Sachets (mesalazine) are now licensed for use in children with mild to...
Top 10 Searches
Latest MIMS Publications
MIMS for Nurses
- Independent Prescriber Formulary December 2009
- Over 1200 updates
- Seven new drug reviews
- Visual guides for respiratory and diabetes devices
GP Curriculum Centre
Educational resource for the learning and teaching of the
GP curriculum
Deleted products
Cumulative list of products discontinued from the UK market
in 2010
MIMs Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
